Funds holding BONE BIOLOGICS CORP
ISIN US0980706008 · United States
- Fund holders
- 3
- Of which ETFs
- 0 3 other funds
- Value held
- 9.2K $
- Share of capital
- 0.3 % of 2.8M shares on Aug 14, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 6,587 | 7.7K $ | 0.24 % | as of Feb 28, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 656 | 767.5 $ | 0.02 % | as of Feb 28, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 625 | 731.3 $ | 0.02 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 3 | 0 | 7,868 | +95.0 % |
| 2026Q1 | 3 | 0 | 4,035 | 0.0 % |
| 2025Q4 | 3 | 4,035 |
Institutional managers
3 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 4,126 | 4.5K $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 230 | 253 $ | as of Mar 31, 2026 |
| UBS Group AG | 56 | 62 $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding BONE BIOLOGICS CORP". https://titelia.com/en/stocks/bone-biologics-corp-US0980706008